Prognostic Factors Influencing the Recurrence Rate and Survival of Patients With Colorectal Cancer: a Single Institution Experience
1 other identifier
observational
200
1 country
1
Brief Summary
over the past decade colon cancer has emerged as the second most deadly and the third most common type of cancer in the world with increasing incidence in Egypt due to life style and diet change. some research showed relation between colon cancer recurrence and advanced tumor staging. To investigators knowledge, this is the first time to be done in Zagazig University. Data was collected from records in a retrospective cohort study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 11, 2024
CompletedFirst Posted
Study publicly available on registry
March 22, 2024
CompletedMarch 22, 2024
March 1, 2024
9.9 years
March 11, 2024
March 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (20)
age
age of patients was obtained from medical records
through study completion, an average of 5 years
sex
sex of patients was obtained from medical records
through study completion, an average of 5 years
medical disease
co-existing medical disease was obtained from medical records
through study completion, an average of 5 years
previous surgery
previous surgical history was obtained from medical records
through study completion, an average of 5 years
CEA
value of carcino-embryonic antigen was recorded
through study completion, an average of 5 years
tumor grade
tumor grade after resection from pathology report recorded
through study completion, an average of 5 years
tumor site
tumor site recorded from operative findings
through study completion, an average of 5 years
tumor size
tumor size was measured by length x width in cm from records
through study completion, an average of 5 years
surgical margins of resected tumor
safety margins were assessed from pathological examination under microscopy and recorded in pathology reports, it can be free surgical margins ( no tumor cells) or positive surgical margins( presence of tumor cells)
through study completion, an average of 5 years
neoadjuvant therapy
history of neoadjuvant therapy before surgery from records obtained
through study completion, an average of 5 years
adjuvant therapy
history of adjuvant therapy post operative obtained from records
through study completion, an average of 5 years
diet
diet and dietary life style from history
through study completion, an average of 5 years
occupation
occupation of the patient at time of surgery and if it was changed
through study completion, an average of 5 years
family history
history taking of family history of cancer disease
through study completion, an average of 5 years
type of surgery(laparoscopic or open)
type of operation was laparoscopic or open surgery obtained from records
through study completion, an average of 5 years
soiling by during surgery
by history from records if there was soiling of the field by tumor cells
through study completion, an average of 5 years
hand sewen or stappled anastmosis
if there was bowel re-anastmosis after surgery, it was done using a stappler or hand sewing sutures. this was obtained from operative data in patient records
through study completion, an average of 5 years
post operative complications
from records; if there were post operative complication like fecal fistula
through study completion, an average of 5 years
site of recurrence
site of tumor recurrence was detected
through study completion, an average of 5 years
type of resected tumor
type of tumor was recorded from pathology reports
through study completion, an average of 5 years
Interventions
resection of bowel segment and re-anastmosis or stoma formation
Eligibility Criteria
patient with newely diagnosed colorectal cancer were followed up after surgery to detect if there was a recurrence prospectively, while patients with recurrent colorectal cancer were studied retrospectively to find out factors influencing the recurrence
You may qualify if:
- Adult patients with newly diagnosed colorectal cancer
- Age \> 18 years old
- recurrent cases of colorectal cancer
You may not qualify if:
- Pediartric patient less than 18 yr
- In operable or metastatic cancer colon
- No other malignancies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig University Hospitals
Zagazig, 44519, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Reham Zakaria, PhD
faculty of medicine Zagazig University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 11, 2024
First Posted
March 22, 2024
Study Start
January 1, 2013
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
March 22, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
data will be available on demand by contacting the principle investigator